Levels of antibodies against citrullinated protein antigens (ACPAs) and inflammatory cytokines involved in RA pathogenesis, such as TNF and IL-6, increase as an individual transitions to clinical disease (2, 3). The gene discussed is IL6; the disease is rheumatoid arthritis.